Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CIMA Announces First European Regulatory Approval Of Organon's Remeron SolTab; Mirtazapine-Based Antidepressant Utilizes CIMA's Fast-Dissolve Technology.


Business Editors & Health/Medical Writers

EDEN PRAIRIE Eden Prairie

A city of eastern Minnesota, a residential suburb of Minneapolis. Population: 57,300.
, Minn.--(BUSINESS WIRE)--July 26, 2001

CIMA LABS INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
. (Nasdaq:CIMA) today announced that its pharmaceutical partner, Organon or·ga·non or or·ga·num
n. pl. or·ga·nons or or·ga·nums or or·ga·na
1. An organ.

2. A set of principles for use in scientific investigation.



organon

pl. organa [Gr.] organ.
, has received its first European marketing approval for Remeron(R) SolTab(TM) from the Dutch Medicines Evaluation Board.

The Dutch regulatory approval triggers a mutual recognition procedure involving other European countries.

Remeron SolTab, an antidepressant antidepressant, any of a wide range of drugs used to treat psychic depression. They are given to elevate mood, counter suicidal thoughts, and increase the effectiveness of psychotherapy.  that incorporates CIMA's OraSolv(R) fast-dissolve drug delivery system with Organon's active drug ingredient, mirtazapine, received U.S. regulatory approval in January 2001 and became commercially available in this year's first quarter.

Remeron, which has been available in the U.S. since 1996 in solid oral dosage form A dosage form is the physical form of a dose of medication, such as a capsule or injection. The route of administration is dependent on the dosage form of a given drug. , has been Organon's best-selling U.S. product. CIMA is Organon's exclusive supplier of Remeron SolTab.

In a separate development, the Company announced that earlier in July, CIMA was included in the Russell 3000(R) Index, a stock market index composed of the 3,000 largest stocks in the U.S. equity market ranked by market capitalization Market Capitalization

A measure of a public company's size. Market capitalization is the total dollar value of all outstanding shares. It's calculated by multiplying the number of shares times the current market price. This term is often referred to as market cap.
 as of May 31.

About CIMA LABS

CIMA develops and manufactures prescription and over-the-counter products for pharmaceutical companies based upon its proprietary, fast-dissolve drug delivery technologies, OraSolv(R) and DuraSolv(TM). CIMA formulates a pharmaceutical company's active drug ingredient into a new, orally disintegrating dosage form that dissolves quickly in the mouth without chewing or the need for water. Taste masking agents may be used with the Company's fast-dissolve technologies to prevent or minimize the unpleasant taste associated with many active drug ingredients. CIMA currently manufactures five pharmaceutical brands utilizing its OraSolv and DuraSolv technologies: three prescription and two over-the-counter.

The information in this press release, including the information related to CIMA's expectations about product developments and introductions, contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. A number of factors could cause actual results to differ materially from CIMA's assumptions and expectations. These risk factors are set forth under the heading "Factors That Could Affect Future Results," included in CIMA's most recent Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the year ended December 31, 2000, filed with the Securities and Exchange Commission. All forward-looking statements are qualified by, and should be considered in conjunction with, such cautionary statements.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 26, 2001
Words:368
Previous Article:CFI Mortgage, Inc. Subsidiary, Surfside Software Systems, Inc., Names Dennis B. Albert National Sales Manager for Desktop Solutions.
Next Article:Ceradyne Inc. Reports Second-Quarter and Six-Months 2001 Financial Results.
Topics:



Related Articles
Ink jets not just for the printed page.
ORGANON GETS FIRST EUROPEAN MARKETING APPROVAL FOR REMERON.
CIMA LABS Announces That Akzo Nobel And Organon Inc. Have Filed Patent Infringement Suit Against Barr Laboratories.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles